Suchergebnisse - "Yada, Masayoshi"

PubPharm (64)

1

Systemic Chemotherapy for Advanced Hepatocellular Carcinoma in Patients With Child-Pugh class B

enthalten in: Cancer diagnosis & prognosis | 2024

von Kuwano, A. | Yada, M. | Tanaka, K. | +4

2

Neutrophil-to-Lymphocyte Ratio Predicts Immune-related Adverse Events in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab

enthalten in: Cancer diagnosis & prognosis | 2024

von Kuwano, A. | Yada, M. | Tanaka, K. | +4

3

Combined Ultrasound and Computed Tomography Guidance in Radiofrequency Ablation for Hepatocellular Carcinoma Reduces Local Recurrence Rate

enthalten in: Cancer diagnosis & prognosis | 2023

von Nagasawa, S. | Kuwano, A. | Tanaka, K. | +3

4

Exploration of Practical Biomarkers for Systemic Drug Therapy for Hepatocellular Carcinoma

enthalten in: Preprints.org | 2023

von Motomura, K. | Kuwano, A. | Tanaka, K. | +3

5

FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy

enthalten in: Experimental and therapeutic medicine | 2023

von Kuwano, A. | Miyazaki, M. | Yada, M. | +4

6

Potential Predictive Biomarkers of Systemic Drug Therapy for Hepatocellular Carcinoma : Anticipated Usefulness in Clinical Practice

enthalten in: Cancers | 2023

von Motomura, K. | Kuwano, A. | Tanaka, K. | +3

7

An Imaging Feature Predicts Efficacy of Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma

enthalten in: Cancer diagnosis & prognosis | 2023

von Kuwano, A. | Yada, M. | Miyazaki, Y. | +5

8

Tumor‑infiltrating CD8+ T cells as a biomarker for chemotherapy efficacy in unresectable hepatocellular carcinoma

enthalten in: Oncology letters | 2023

von Kuwano, A. | Yada, M. | Miyazaki, Y. | +5

9

Risk factors for loss to follow-up after the start of direct-acting antiviral treatment for hepatitis C virus infection

enthalten in: JGH open : an open access journal of gastroenterology and hepatology | 2023

von Kuwano, A. | Yada, M. | Kurosaka, K. | +3

10

Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection

enthalten in: JGH Open | 2023

von Kuwano, A. | Yada, M. | Kurosaka, K. | +3

1
2
3
4
5
6
7
Nächster »
[7]